Harmony Biosciences Holdings, Inc. HRMY Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $145.62M-8.2% | $158.69M-14.5% | $185.68M+2.6% | $180.9M+18.5% | $152.72M+5.0% | ||
| —— | —— | $26K0.0% | $26K-76.6% | $111K-58.4% | ||
| $43.02M-4.2% | $44.9M-0.2% | $45M-0.2% | $45.07M+0.8% | $44.71M+4.9% | ||
| —— | —— | -$21.39M+4.2% | -$22.34M+25.9% | -$30.13M-2.8% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $457K— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$30.79M+3.1% | -$31.79M— | —— | —— | —— | ||
| $27.27M-59.9% | $67.99M+142% | $28.12M+15.2% | $24.41M+67.5% | $14.57M+23.5% | ||
| $1.43M+7.0% | $1.33M-5.6% | $1.41M-25.9% | $1.91M-9.2% | $2.1M0.0% | ||
| $23.85M0.0% | $23.85M0.0% | $23.85M0.0% | $23.85M0.0% | $23.85M0.0% | ||
| $341.97M-1.8% | $348.2M+17.0% | $297.61M+14.7% | $259.38M+16.5% | $222.67M+1.3% | ||
| —— | $310K-56.7% | $716K+10.5% | $648K-49.2% | $1.28M+10.7% | ||
| $246.01M+186% | $86.15M-16.4% | $103M+1.0% | $102M+2.7% | $99.32M-5.7% | ||
| $86.79M+7.1% | $81.06M-10.4% | $90.51M-4.7% | $94.98M-6.2% | $101.22M+2.7% | ||
| -$225.66M-469% | -$39.65M-35.8% | -$29.2M-19.6% | -$24.41M+59.1% | -$59.68M+12.5% | ||
| $17.5M+7.7% | $16.25M+8.3% | $15M0.0% | $15M0.0% | $15M0.0% | ||
| $5.85M-42.7% | $10.21M-5.5% | $10.79M-14.4% | $12.62M+13.7% | $11.09M+70.6% | ||
| $4.26M+41.8% | $3M-34.3% | $4.57M— | —— | —— | ||
| -$15.92M-75.9% | -$9.05M-3.1% | -$8.78M-26.2% | -$6.95M+9.9% | -$7.71M+29.8% | ||
| $100.4M-66.5% | $299.5M+15.4% | $259.63M+13.5% | $228.75M— | —— | ||
| $13.81M-5.9% | $14.69M-4.1% | $15.32M-4.5% | $16.03M-5.3% | $16.93M-2.2% | ||
| $1.29M-15.2% | $1.52M-12.1% | $1.73M-11.0% | $1.95M-8.2% | $2.12M-6.3% | ||
| $632K-2.3% | $647K-1.8% | $659K-2.1% | $673K-1.9% | $686K-2.0% | ||
| $23.85M0.0% | $23.85M0.0% | $23.85M0.0% | $23.85M0.0% | $23.85M0.0% | ||
| —— | —— | $26K0.0% | $26K-76.6% | $111K-58.4% | ||
| —— | $1.49M+25.8% | $1.18M+34.8% | $878.5K+53.4% | $572.75K+115% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$30.79M+3.1% | -$31.79M— | —— | —— | —— | ||
| -$198K-405% | $65K— | —— | —— | —— | ||
| $43.25M+188% | $15M-14.9% | $17.63M-13.0% | $20.25M-11.5% | $22.88M-10.3% | ||
| $86.79M+7.1% | $81.06M-10.4% | $90.51M-4.7% | $94.98M-6.2% | $101.22M+2.7% | ||
| —— | $347.89M+17.2% | $296.89M+14.8% | $258.73M+16.9% | $221.39M+1.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Harmony Biosciences Holdings, Inc. generate?
- Harmony Biosciences Holdings, Inc. (HRMY) generated $342.0M in operating cash flow over the trailing twelve months.
- Where does Harmony Biosciences Holdings, Inc.'s cash flow data come from?
- Every line is extracted from Harmony Biosciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
